|
1.
Diabetes And Vascular Education (dave.md): The Skeletal Hormone ... Aug 17, 2007 ... Esp is important in the ÿ-carboxilation, which is the main post-translational modification of osteocalcin. These data suggest that the ... 2.
dave.md: Functional Status in BARI 2D Patients Dr. Beohar and colleagues evaluated 2321 subjects enrolled in the BARI 2D trial with type 2 diabetes and coronary artery disease. ... 3.
Diabetes And Vascular Education (DAVE.md): Ranolazine Reduces ... Nov 6, 2007 ... AHA 2007: Ranolazine Reduces Hemoglobin A1c in Diabetic Patients ... Among all patients, mean A1c was 5.9% in patients randomized to ... 4.
Novartis committed to making Galvus® available for patients with ... File Format: PDF/Adobe Acrobat - View as HTML Discussions to continue with the FDA to obtain final US approval for Galvus. Basel, February 26, 2007 - Novartis announced today that it has received an ... 5.
Novartis committed to making Galvus® available for patients with ... File Format: PDF/Adobe Acrobat - View as HTML Feb 26, 2007 ... from the US Food and Drug Administration (FDA) for Galvus® (vildagliptin), under review for US approval as a new once-daily oral treatment ... 6.
PROACTIVE RESPONSE TO NICE CLINICAL GUIDANCE - TYPE 2 DIABETES ... File Format: PDF/Adobe Acrobat - View as HTML May 28, 2008 ... are currently being considered by NICE as part of a rapid update. Approximately eighty percent of type 2 diabetes patients remain ... 7.
Diabetes and Vascular Education - Dave.md Summary: Dr. Dominick Angiolillo, MD PhD, Director of Thrombosis Research and Associate ... Management of Diabetes and Heart Failure (Silvio Inzucchi, MD) ... 8.
Novartis committed to making Galvus® available for patients with ... File Format: PDF/Adobe Acrobat - View as HTML Discussions to continue with the FDA to obtain final US approval for Galvus. Basel, February 26, 2007 - Novartis announced today that it has received an ... 9.
dave.md: Professor JP Despres Discusses Rimonabant Jul 16, 2007 ... Despres JP, Golay A, Sjostrom L, et al. Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia. ... 10.
Diabetes and Vascular Education - Dave.md - News - Scientific ... Transcatheter Cardiovascular Therapeutics ... (MATRIX) registry at the Transcatheter Cardiovascular Therapeutics (TCT) 18th Annual Scientific Symposium More ... |
